𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulation of cellular growth by sodium pump activity

✍ Scribed by Brenda Buckhold Shank; Nancy Egan Smith


Book ID
102884404
Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
764 KB
Volume
87
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Cellular growth has been found to be directly related to the amount of sodium pumping activity in mouse lymphoblasts (L5178‐Y) cultured in varying concentrations of the cardiac glycoside, ouabain. No short‐term adaptation (within one generation) occurred; i.e., neither growth rate nor (Na^+^ + K^+^)‐ATPase activity increased in cells cultured for 1–2 days in ouabain.

Growth inhibition commenced after two hours, occurring concomitantly with decreased ^3^H‐leucine incorporation into protein. The time course of this inhibition of protein synthesis, measured by leucine incorporation was similar to, but slightly slower than the time course of the dissipation of the sodium gradient. On the other hand, ^3^H‐thymidine incorporation is unaffected by ouabain treatment over the same period. The uptake of ^3^H‐alanine, a neutral amino acid thought to be transported via a Na^+^‐dependent carrier, was depressed concurrently with the sodium gradient dissipation. It is suggested, therefore, that ouabain inhibition of cellular growth results primarily from the dissipation of the sodium gradient leading to decreased Na^+^‐dependent transport of amino acids (e.g., alanine) and, therefore, decreased protein synthesis, as observed by leucine incorporation.

A sensitive and rapid method for determining ouabain inhibition of cell volume regulation is also described, which may prove potentially useful for assaying Na pump activity.


📜 SIMILAR VOLUMES


Activation of the androgen receptor by p
✍ Z. Culig; A. Hobisch; M. V. Cronauer; A. Hittmair; C. Radmayr; G. Bartsch; H. Kl 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 636 KB

The polypeptide growth factors insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), and transforming growth factor-alpha (TGF-alpha); second-messenger cyclic adenosine monophosphate (cAMP): protein kinase activators; and neurotransmitters were found to activate the estrogen (ER), pro